SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040986
Filing Date
2023-11-14
Accepted
2023-11-14 15:11:32
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1120948
2 ex31-1.htm EX-31.1 18481
3 ex31-2.htm EX-31.2 18354
4 ex32-1.htm EX-32.1 9716
  Complete submission text file 0001493152-23-040986.txt   5729062

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20230930.xsd EX-101.SCH 42677
6 XBRL CALCULATION FILE biaf-20230930_cal.xml EX-101.CAL 65632
7 XBRL DEFINITION FILE biaf-20230930_def.xml EX-101.DEF 158547
8 XBRL LABEL FILE biaf-20230930_lab.xml EX-101.LAB 369665
9 XBRL PRESENTATION FILE biaf-20230930_pre.xml EX-101.PRE 278233
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 937618
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41463 | Film No.: 231404948
SIC: 8731 Services-Commercial Physical & Biological Research